209 related articles for article (PubMed ID: 14871278)
21. The value of a baseline liver biopsy prior to methotrexate treatment.
Dolan OM; Burrows D; Irvine A; Walsh M
Br J Dermatol; 1994 Dec; 131(6):891-4. PubMed ID: 7857846
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate for psoriasis in the era of biological therapy.
Warren RB; Chalmers RJ; Griffiths CE; Menter A
Clin Exp Dermatol; 2008 Aug; 33(5):551-4. PubMed ID: 18801095
[TBL] [Abstract][Full Text] [Related]
23. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
Khan S; Subedi D; Chowdhury MM
Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
[TBL] [Abstract][Full Text] [Related]
24. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis.
Ashton RE; Millward-Sadler GH; White JE
J Invest Dermatol; 1982 Oct; 79(4):229-32. PubMed ID: 7130740
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
Gilbert SC; Klintmalm G; Menter A; Silverman A
Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
[TBL] [Abstract][Full Text] [Related]
26. Liver biopsies and methotrexate: a time for reconsideration?
Zachariae H
J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
[No Abstract] [Full Text] [Related]
27. Liver damage due to methotrexate in patients with psoriasis.
Dahl MG; Gregory MM; Scheuer PJ
Br Med J; 1971 Mar; 1(5750):625-30. PubMed ID: 5548839
[TBL] [Abstract][Full Text] [Related]
28. Dynamic hepatic scintigraphy in the screening of psoriatic patients for methotrexate-induced hepatotoxicity.
McHenry PM; Bingham EA; Callender ME; Delvin PB; O'Hara MD; Ferguson WR; Laird JD; Burrows D
Br J Dermatol; 1992 Aug; 127(2):122-5. PubMed ID: 1390139
[TBL] [Abstract][Full Text] [Related]
29. [Serum liver tests in patients treated with methotrexate. A retrospective analysis].
Correa G H; Paredes S N
Rev Med Chil; 2007 Aug; 135(8):1002-8. PubMed ID: 17989857
[TBL] [Abstract][Full Text] [Related]
30. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
Kumar B; Saraswat A; Kaur I
Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
Zachariae H; Søgaard H; Heickendorff L
Dermatology; 1996; 192(4):343-6. PubMed ID: 8864370
[TBL] [Abstract][Full Text] [Related]
32. Morphogenesis of fibrosis and cirrhosis in methotrexate-treated patients with psoriasis.
Nyfors A; Poulsen H
Am J Surg Pathol; 1977 Sep; 1(3):235-43. PubMed ID: 920871
[TBL] [Abstract][Full Text] [Related]
33. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate and histologic hepatic abnormalities: a meta-analysis.
Whiting-O'Keefe QE; Fye KH; Sack KD
Am J Med; 1991 Jun; 90(6):711-6. PubMed ID: 1828327
[TBL] [Abstract][Full Text] [Related]
35. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
Berends MA; van Oijen MG; Snoek J; van de Kerkhof PC; Drenth JP; Han van Krieken J; de Jong EM
Arch Dermatol; 2007 Dec; 143(12):1515-9. PubMed ID: 18087000
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
Malatjalian DA; Ross JB; Williams CN; Colwell SJ; Eastwood BJ
Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
[TBL] [Abstract][Full Text] [Related]
37. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.
Maybury CM; Jabbar-Lopez ZK; Wong T; Dhillon AP; Barker JN; Smith CH
Br J Dermatol; 2014 Jul; 171(1):17-29. PubMed ID: 24606161
[TBL] [Abstract][Full Text] [Related]
39. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
Mathew J; Leong MY; Morley N; Burt AD
BMC Dermatol; 2005 Nov; 5():12. PubMed ID: 16316460
[TBL] [Abstract][Full Text] [Related]
40. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]